On Monday, Annovis Bio Inc (NYSE: ANVS) was -5.49% drop from the session before settling in for the closing price of $4.55. A 52-week range for ANVS has been $1.11 – $6.37.
A company in the Healthcare sector has dropped its sales by -73.95% annually for the last half of the decade. When this article was written, the company’s average yearly earnings per share was at 42.00%. With a float of $22.39 million, this company’s outstanding shares have now reached $26.50 million.
Annovis Bio Inc (ANVS) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Annovis Bio Inc stocks. The insider ownership of Annovis Bio Inc is 15.51%, while institutional ownership is 11.40%. The most recent insider transaction that took place on Dec 08 ’25, was worth 193,794. In this transaction Director of this company bought 45,000 shares at a rate of $4.31, taking the stock ownership to the 2,574,739 shares. Before that another transaction happened on Nov 24 ’25, when Company’s Director bought 39,200 for $4.08, making the entire transaction worth $159,886. This insider now owns 2,519,739 shares in total.
Annovis Bio Inc (ANVS) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 42.00% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 18.51% during the next five years compared to -73.95% drop over the previous five years of trading.
Annovis Bio Inc (NYSE: ANVS) Trading Performance Indicators
You can see what Annovis Bio Inc (ANVS) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 4.60.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.48, a number that is poised to hit -0.34 in the next quarter and is forecasted to reach -1.40 in one year’s time.
Technical Analysis of Annovis Bio Inc (ANVS)
Let’s dig in a bit further. During the last 5-days, its volume was 1.0 million. That was better than the volume of 0.8 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 40.36%.
During the past 100 days, Annovis Bio Inc’s (ANVS) raw stochastic average was set at 69.47%, which indicates a significant increase from 52.38% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.58 in the past 14 days, which was higher than the 0.23 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.72, while its 200-day Moving Average is $2.30. However, in the short run, Annovis Bio Inc’s stock first resistance to watch stands at $4.53. Second resistance stands at $4.75. The third major resistance level sits at $4.96. If the price goes on to break the first support level at $4.10, it is likely to go to the next support level at $3.89. The third support level lies at $3.67 if the price breaches the second support level.
Annovis Bio Inc (NYSE: ANVS) Key Stats
There are 26,503K outstanding shares of the company, which has a market capitalization of 113.96 million. As of now, sales total 0 K while income totals -24,590 K. Its latest quarter income was 0 K while its last quarter net income were -7,260 K.
